Evidence map›Paper›PMID 42520047›Full record

ArticlePLoS pathogens2026

A novel stress response pathway mediates biofilm architecture in Pseudomonas aeruginosa.

Ainelen Piazza, Catriona M A Thompson, Govind Chandra, Harshanie Dasanayaka, Gerhard Saalbach, Carlo Martins, Eleftheria Trampari, Mark A Webber, Freya Harrison, Jacob G Malone

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ainelen PiazzaDepartment of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, United Kingdom.
Catriona M A ThompsonDepartment of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, United Kingdom.
Govind ChandraDepartment of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, United Kingdom.
Harshanie DasanayakaDepartment of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, United Kingdom.
Gerhard SaalbachJohn Innes Centre Proteomics Platform, Norwich, United Kingdom.
Carlo MartinsJohn Innes Centre Proteomics Platform, Norwich, United Kingdom.
Eleftheria TrampariThe Centre for Microbial Interactions, Norwich Research Park, Norwich, United Kingdom.
Mark A WebberThe Centre for Microbial Interactions, Norwich Research Park, Norwich, United Kingdom.
Freya HarrisonSchool of Life Sciences, Gibbet Hill Campus, The University of Warwick, Coventry, United Kingdom.
Jacob G MaloneDepartment of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, United Kingdom.ORCID 0000-0003-1959-6820

Funding

BBSRCBBSRC BBS/E/J/000PR9797BBSRC BB/T004363/1BBSRC BB/X010996/1BBSRC BB/X011011/1MRC
6 · The paper itself

Abstract

Pseudomonas aeruginosa is a multidrug-resistant opportunistic pathogen, with chronic infections often associated with biofilm formation. Here, we investigate the previously uncharacterized gene PA3049, which is upregulated under biofilm conditions, to determine its role in infection, biofilm formation, and antimicrobial sensitivity. We show that the small uncharacterised protein PA3049, renamed as Biofilm architecture Regulator (BatR), promotes biofilm establishment and enhances biofilm survival in sub-inhibitory concentrations of antibiotics. Proteomic analysis revealed that BatR influences the R2/F2 pyocin cluster, which drives explosive cell lysis and extracellular DNA (eDNA) release during biofilm development. We further identify a specific interaction between BatR and PA0486 (SrkA), an uncharacterised Ser/Thr protein kinase. We show that SrkA controls biofilm and pyocyanin production, and lysis-mediated eDNA release through regulation of the R2/F2 pyocin cluster and activation of bacteriophage Pf4. Our findings support a model in which SrkA directly regulates key biofilm-associated phenotypes, while BatR acts as a modulatory partner that tunes SrkA activity under specific conditions. Finally, BatR function was tested in high-validity infection models, including the ex vivo pig lung model of cystic fibrosis infection and a synthetic chronic-wound model. In these models, BatR contributes to biofilm architecture and antibiotic resistance and modulates pyocyanin production. Our study implicates the BatR/SrkA system in the response of P. aeruginosa biofilms to antibiotic challenge in lung infections.

Indexed as

Bacterial ProteinsBiofilmsPseudomonas aeruginosaPseudomonas InfectionsStress, PhysiologicalAnimalsAnti-Bacterial AgentsGene Expression Regulation, BacterialPyocinsAnti-Bacterial AgentsBacterial ProteinsPyocins

Identifiers

PMID42520047
PMCPMC13411936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.